CT Prediction for Transcatheter Tricuspid Interventions

Launched by HEART AND DIABETES CENTER NORTH-RHINE WESTFALIA · Apr 22, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how to better predict which patients will benefit from a specific type of heart procedure called transcatheter tricuspid valve intervention (TTVI) for those suffering from severe tricuspid regurgitation (TR). TR is a condition where the heart’s tricuspid valve does not close properly, leading to blood leaking backward into the heart. This trial aims to use advanced computer technology, including artificial intelligence, to analyze detailed CT scans of patients’ hearts before the procedure. By doing this, researchers hope to find out which techniques work best for different patients, improving their chances of a successful outcome and a better quality of life.

To participate in this trial, individuals must be at least 18 years old, have had a CT scan to assess their heart condition, and be scheduled for a TTVI procedure. There are no specific exclusions, so most patients with the right heart issues can join. Participants can expect to receive personalized care and attention during the trial, as researchers closely monitor their progress and treatment results. This study is currently recruiting participants, and it represents an important step toward improving heart care for patients with serious valve problems.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • the patient underwent full cycle cardiac computed tomography for analysis of valvular heart disease
• • a transcatheter tricuspid valve intervention is performed
• • the patient is 18 years or older
• Exclusion Criteria:
• • none